INTERNATIONAL PATENT: PRINCIPIA BIOPHARMA INC. FILES APPLICATION FOR "RILZABRUTINIB FOR USE IN THE TREATMENT OF ITCH ASSOCIATED WITH ATOPIC DERMATITIS AND/OR PRURIGO NODULARIS"

GENEVA, May 6 -- PRINCIPIA BIOPHARMA INC. (55 Corporate DriveBridgewater, New Jersey 08807) filed a patent application (PCT/US2024/052716) for "RILZABRUTINIB FOR USE IN THE TREATMENT OF ITCH ASSOCIATED WITH ATOPIC DERMATITIS AND/OR PRURIGO NODULARIS" on Oct 24, 2024. With publication no. WO/2025/090702, the details related to the patent application was published on May 01, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BARET-CORMEL, Lydie (c/o Sanofi, Patent Department46 avenue de la Grande Armee75017 Paris), MANNENT, Leda (c/o Sanofi, Patent Department46 avenue de la Grande Armee75017 Pari...